ZA916642B - Codeine salt of a substituted carboxylic acid,processes for the preparation thereof,its use and pharmaceutical compositions - Google Patents

Codeine salt of a substituted carboxylic acid,processes for the preparation thereof,its use and pharmaceutical compositions

Info

Publication number
ZA916642B
ZA916642B ZA916642A ZA916642A ZA916642B ZA 916642 B ZA916642 B ZA 916642B ZA 916642 A ZA916642 A ZA 916642A ZA 916642 A ZA916642 A ZA 916642A ZA 916642 B ZA916642 B ZA 916642B
Authority
ZA
South Africa
Prior art keywords
processes
preparation
pharmaceutical compositions
carboxylic acid
salt
Prior art date
Application number
ZA916642A
Other languages
English (en)
Inventor
Walter Riess
Riess Walter
Alfred Sallman
Sallman Alfred
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA916642B publication Critical patent/ZA916642B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA916642A 1990-08-23 1991-08-22 Codeine salt of a substituted carboxylic acid,processes for the preparation thereof,its use and pharmaceutical compositions ZA916642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH273590 1990-08-23

Publications (1)

Publication Number Publication Date
ZA916642B true ZA916642B (en) 1992-04-29

Family

ID=4240432

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916642A ZA916642B (en) 1990-08-23 1991-08-22 Codeine salt of a substituted carboxylic acid,processes for the preparation thereof,its use and pharmaceutical compositions

Country Status (20)

Country Link
US (1) US5190947A (en, 2012)
EP (1) EP0472501B1 (en, 2012)
JP (1) JPH04257587A (en, 2012)
KR (1) KR920004391A (en, 2012)
AT (1) ATE137753T1 (en, 2012)
AU (1) AU652951B2 (en, 2012)
CA (1) CA2049649A1 (en, 2012)
DE (1) DE59107784D1 (en, 2012)
DK (1) DK0472501T3 (en, 2012)
ES (1) ES2086515T3 (en, 2012)
FI (1) FI96421C (en, 2012)
GR (1) GR3019872T3 (en, 2012)
HU (1) HU209308B (en, 2012)
IE (1) IE72479B1 (en, 2012)
IL (1) IL99213A (en, 2012)
NO (1) NO179175C (en, 2012)
NZ (1) NZ239495A (en, 2012)
PT (1) PT98731B (en, 2012)
TW (1) TW225536B (en, 2012)
ZA (1) ZA916642B (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498011B1 (de) * 1991-02-07 1995-04-26 HEUMANN PHARMA GMBH & CO Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
CA2304722C (en) * 1997-09-25 2005-11-22 Lts Lohmann Therapie-Systeme Ag Acidic addition salts of morphine alkaloids and the application thereof
AU2002305816B2 (en) * 2001-06-05 2008-04-10 Psivida Us Inc. Sustained-release analgesic compounds
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8557291B2 (en) * 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
CA2916869A1 (en) * 2004-06-12 2005-12-29 Jane C. Hirsh Abuse-deterrent drug formulations
US20090291121A1 (en) * 2008-05-23 2009-11-26 Symrise, Inc. Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
BRPI1006222A2 (pt) 2009-03-12 2016-08-02 Cumberland Pharmaceuticas Inc uso de ibuprofeno na redução de dor em pacientes humanos que são submetidos a cirurgia, uso de ibuprofeno na redução de dor cirúrgica em pacientes humanos e uso de ibuprofeno para melhorar o tempo ambulatorial após a operação em pacientes humanos que sorem procedimentos cirúrgicos ortopédicos
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2013112456A1 (en) 2012-01-24 2013-08-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Controlled release formulations for the induction and proliferation of blood cells
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA537946A (en) * 1957-03-12 J. Lewenstein Mozes Process for preparing improved compounds having narcotic effect
US936254A (en) * 1908-01-06 1909-10-05 Belden Mfg Co Attachment for telephones.
DE377588C (de) * 1922-08-29 1923-06-22 O Hinsberg Dr Verfahren zur Darstellung einer salzartigen Verbindung des Codeins
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US3895063A (en) * 1965-04-08 1975-07-15 Ciba Geigy Corp Substituted Anilino Benzyl Alcohols
FR2051482B1 (en, 2012) * 1969-04-04 1973-06-08 Rabot Ets David
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
FR2257606B1 (en, 2012) * 1974-01-10 1978-02-24 Sumitomo Chemical Co
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
FI96421B (fi) 1996-03-15
NO179175B (no) 1996-05-13
IE912973A1 (en) 1992-02-26
IL99213A (en) 1995-07-31
HUT60501A (en) 1992-09-28
IE72479B1 (en) 1997-04-23
ATE137753T1 (de) 1996-05-15
PT98731A (pt) 1992-07-31
NO913295L (no) 1992-02-24
FI913949L (fi) 1992-02-24
HU209308B (en) 1994-04-28
JPH04257587A (ja) 1992-09-11
US5190947A (en) 1993-03-02
HU912768D0 (en) 1992-01-28
CA2049649A1 (en) 1992-02-24
FI913949A0 (fi) 1991-08-21
FI96421C (fi) 1996-06-25
KR920004391A (ko) 1992-03-27
EP0472501B1 (de) 1996-05-08
ES2086515T3 (es) 1996-07-01
EP0472501A3 (en) 1993-02-24
DK0472501T3 (da) 1996-05-28
AU8268591A (en) 1992-02-27
IL99213A0 (en) 1992-07-15
PT98731B (pt) 1999-01-29
DE59107784D1 (de) 1996-06-13
NZ239495A (en) 1997-05-26
NO913295D0 (no) 1991-08-22
EP0472501A2 (de) 1992-02-26
GR3019872T3 (en) 1996-08-31
NO179175C (no) 1996-08-21
TW225536B (en, 2012) 1994-06-21
AU652951B2 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
IL99213A0 (en) Codeine salt of a substituted carboxylic acid,processes for the preparation thereof,its use and pharmaceutical compositions
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GR3019796T3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
RU98103388A (ru) (r)-5-бром-n-(1-этил-4-метилгексагидро-1н-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения и фармацевтическая композиция, содержащая указанное соединение
AU1300383A (en) Amides useful in the treatment of diabetes
HUT49614A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds
ATE6640T1 (de) N-benzoyl-alpha-anilinoalkylcarboxylsaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
IE822853L (en) 1-piperazino carboxylates
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
IL86169A (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
JPS57142961A (en) Basic substituted anthranilic acid
ATE149T1 (de) 2-(n-(2'-chlor-4'-methylthienyl-3')-n-(cyclopropyl- methyl)-amino)-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung.
ZA828127B (en) Pyridazinone-imines and their physiologically tolerated acid addition salts, their preparation, and therapeutic agents containing these compounds
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
RU99108789A (ru) Ингибитор субэпителиального помутнения роговицы